Zhao Cao
Nanning, 530021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Targeting metabolic dysregulation in HCC: Development and validation of a dual-biomarker diagnostic model integrating ADH1C and BHMT.
Journal: Clinics and research in hepatology and gastroenterology
Published: December 07, 2025
CKAP4 and PLOD2 as novel prognostic biomarkers in hepatocellular carcinoma: a proteomics-driven risk stratification model.
Journal: Frontiers in cell and developmental biology
Published: February 15, 2025
Development of a Reliable GADSAH Model for Differentiating AFP-negative Hepatic Benign and Malignant Occupying Lesions.
Journal: Journal of hepatocellular carcinoma
Published: December 08, 2023
Nascent Proteome and Glycoproteome Reveal the Inhibition Role of ALG1 in Hepatocellular Carcinoma Cell Migration.
Journal: Phenomics (Cham, Switzerland)
Published: December 12, 2021
Quantification of Intact O-Glycopeptides on Haptoglobin in Sera of Patients With Hepatocellular Carcinoma and Liver Cirrhosis.
Journal: Frontiers in chemistry
Published: May 05, 2021
Analysis of Serum Paraoxonase 1 Using Mass Spectrometry and Lectin Immunoassay in Patients With Alpha-Fetoprotein Negative Hepatocellular Carcinoma.
Journal: Frontiers in oncology
Published: January 12, 2021
Diagnostic value of platelet-lymphocyte ratio and hemoglobin-platelet ratio in patients with rectal cancer.
Journal: Journal of clinical laboratory analysis
Published: August 29, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026